Qiao Mu and Haoran Sun of Qingshang Partners examine the legal frameworks of the five Central Asian countries, highlighting common investment pitfalls with case examples and exploring how Chinese investors are adapting their legal strategies to navigate this complex but promising region
U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be bound by non-compete clauses; and Some stablecoin issuers complain that Hong Kong’s regime is too stringent.
Court interpretation of rules governing mandatory social insurance payments causes backlash; Proposed changes to implementation of China’s VAT regime aim to clarify gray areas; and Arkansas joins push to divest pension funds from China.
Hainan launches pilot program expanding financial products access to foreigners; Chinese companies reconsider pivot to Southeast Asia as region targeted by U.S. tariffs; and Chinese regulator puts U.S. outbound investments on hold.
China rolls out tax breaks for foreign investors reinvesting profits locally; China remains key private equity market but firms are starting to diversify investments; U.S. Congressional bill that targets Chinese AI tools like Deepseek has bipartisan support
Chinese manufacturers increase exports to non-U.S. markets; Revisions to the Anti-Unfair Competition Law address challenges to fair competition; China's data centers in Tibet aim to power much of China's AI
U.S. to tighten disclosure obligations of foreign listed companies, targeting China; China to allow local investors to invest more in overseas assets under QDII; and EU issues measures to restrict Chinese medical device manufacturers from accessing public procurement contracts
Chinese exporters ship goods through third countries to conceal true origin; China’s stringent cross-border data transfer rules force European pause in funding of scientific research; and Draft revisions of arbitration law aim to increase oversight and international cooperation on arbitration cases
